Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "ubiquinol-cytochrome c reductase binding protein pseudogene" is a human pseudogene related to the UQCRB gene, which encodes a subunit of mitochondrial complex III. Unlike functional genes, a pseudogene is a genomic DNA sequence similar to a gene but typically nonfunctional due to mutations or a lack of expression. This means it does not encode a protein and is not part of the mitochondrial respiratory chain[5][8]. No evidence supports its use as a receptor, therapeutic target, or marker for disease or therapy monitoring. The designation is problematic for drug target purposes because: - It is a pseudogene and not a protein or functional RNA product. - Pseudogenes, by definition, do not normally encode functional proteins or possess clear biological functions[5][8]. - The canonical drug target "ubiquinol-cytochrome c reductase binding protein" refers instead to the UQCRB protein, which is encoded by a different, protein-coding gene (ENSG00000156467), not this pseudogene[1][3]. - The gene symbol ENSG00000254373 is clearly marked as a pseudogene (e.g., as UQCRBP1)[7]. - Such pseudogenes are not considered therapeutic targets in pharmacology, biomedicine, or drug discovery[5][8]. If structured information about the canonical therapeutic target is required, the correct entity is "ubiquinol-cytochrome c reductase binding protein" (UQCRB), not this pseudogene. The current entry should not be treated as a valid molecular target for drug discovery, diagnostics, or therapeutic interventions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ubiquinol-cytochrome c reductase binding protein pseudogene (null).